Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Juliane Haedicke-Jarboui"'
Autor:
Jasmin Fertey, Jörg Hagmann, Hans‐Joachim Ruscheweyh, Christian Munk, Susanne Kjaer, Daniel Huson, Juliane Haedicke‐Jarboui, Frank Stubenrauch, Thomas Iftner
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1058-1068 (2020)
Abstract Several studies have demonstrated that the viral genome can be methylated by the host cell during progression from persistent infection to cervical cancer. The aim of this study was to investigate whether methylation at a specific site could
Externí odkaz:
https://doaj.org/article/6f62c698defa435bb9517ce21dbf8b2f
Autor:
Thomas Iftner, Lisa Wang, Angelika Iftner, Barbara Holz, Juliane Haedicke-Jarboui, Nathalie Iftner, Reinhard von Wasielewski, Peter Martus, Gerd Boehmer
Publikováno v:
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-9 (2016)
Abstract Background High-risk human papillomavirus (HR HPV) testing is already part of cervical cancer screening programs in a number of countries. New tests need to be validated not only in clinical studies but also in routine screening settings wit
Externí odkaz:
https://doaj.org/article/4cf6af8385114989a41d145cf3c40eff
Publikováno v:
International Journal of Cancer. 144:2330-2338
Although a vast amount of research underlines the roles of the HR HPV E6 and E7 oncogenes in HPV-induced carcinogenesis of cervical cancer, it remains unclear whether these oncogenes are also involved in the resistance of the cancer against chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c86d73f1e4a79c7ef54ee48b293bf3de
https://doi.org/10.1002/ijc.31986
https://doi.org/10.1002/ijc.31986
Autor:
Alejandra Castanon, Sara Y. Brucker, Rebecca Landy, Claus Hann von Weyhern, Juliane Haedicke-Jarboui, Barbara Holz, Melanie Henes, Felix Neis, Thomas Iftner, Annette Staebler, Klaus-Joachim Neis, Peter Martus, Angelika Iftner, Diethelm Wallwiener, Astrid Woll-Herrmann, Peter Sasieni
Publikováno v:
Iftner, T, Neis, K-J, Castanon, A, Landy, R, Holz, B, Woll-Herrmann, A, Iftner, A, Staebler, A, Wallwiener, D, von Weyhern, C H, Neis, F, Haedicke-Jarboui, J, Martus, P, Brucker, S, Henes, M & Sasieni, P 2019, ' Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany ', Journal of Clinical Microbiology, vol. 57, no. 1, e01177 . https://doi.org/10.1128/JCM.01177-18
Journal of Clinical Microbiology
Journal of Clinical Microbiology
Longitudinal data on the E6/E7 mRNA-based Aptima human papillomavirus (AHPV) assay exceeding three years in comparison to the gold standard Digene Hybrid Capture 2 (HC2) test are not available. We previously reported the cross-sectional data of the G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e4389dd71c2a3aa5feb02b0c479ca5
https://kclpure.kcl.ac.uk/ws/files/108890998/Journal_of_Clinical_Microbiology_2018_Iftner_JCM.01177_18.full.pdf
https://kclpure.kcl.ac.uk/ws/files/108890998/Journal_of_Clinical_Microbiology_2018_Iftner_JCM.01177_18.full.pdf
Publikováno v:
International journal of cancer. 144(9)
Although a vast amount of research underlines the roles of the HR HPV E6 and E7 oncogenes in HPV-induced carcinogenesis of cervical cancer, it remains unclear whether these oncogenes are also involved in the resistance of the cancer against chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::31d448cad706fd9ca2b3b930a83b3c2c
https://pubmed.ncbi.nlm.nih.gov/30421459
https://pubmed.ncbi.nlm.nih.gov/30421459
Publikováno v:
Virus research. 231
Bromodomain-containing protein 4 (Brd4) is a cellular chromatin-binding factor and transcriptional regulator that recruits sequence-specific transcription factors and chromatin modulators to control target gene transcription. Papillomaviruses (PVs) h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c4921bba77cf11b216f8dd712d94d99
https://pubmed.ncbi.nlm.nih.gov/27965149
https://pubmed.ncbi.nlm.nih.gov/27965149
Autor:
Thomas Iftner, Lisa Wang, Angelika Iftner, Barbara Holz, Juliane Haedicke-Jarboui, Nathalie Iftner, Reinhard von Wasielewski, Peter Martus, Gerd Boehmer
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-9 (2016)
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-9 (2016)
Background High-risk human papillomavirus (HR HPV) testing is already part of cervical cancer screening programs in a number of countries. New tests need to be validated not only in clinical studies but also in routine screening settings with regard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::144c7b4faeca723f2007eb4afa3159c3
Autor:
Manawapat-Klopfer A, Lt, Thomsen, Martus P, Munk C, Russ R, Gmuender H, Frederiksen K, Juliane Haedicke-Jarboui, Stubenrauch F, Sk, Kjaer, Iftner T
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2766a994bfa97018a3174bb160679bee
http://europepmc.org/abstract/med/27508094
http://europepmc.org/abstract/med/27508094
Autor:
Fertey, Jasmin1 (AUTHOR), Hagmann, Jörg2 (AUTHOR), Ruscheweyh, Hans‐Joachim3 (AUTHOR), Munk, Christian4 (AUTHOR), Kjaer, Susanne4 (AUTHOR), Huson, Daniel3 (AUTHOR), Haedicke‐Jarboui, Juliane1 (AUTHOR), Stubenrauch, Frank1 (AUTHOR), Iftner, Thomas1 (AUTHOR) thomas.iftner@med.uni-tuebingen.de
Publikováno v:
Cancer Medicine. Feb2020, Vol. 9 Issue 3, p1058-1068. 11p.
Publikováno v:
International Journal of Cancer; May2019, Vol. 144 Issue 9, p2330-2338, 9p